Full Year 2019 Adaptimmune Therapeutics PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Q3 2019 Adaptimmune Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the call over to Juli Miller. Please go ahead.
Good morning, and welcome to Adaptimmune's conference call to discuss our third quarter 2019 financial results and other business updates. We issued a press release earlier this morning, and I would ask you to please review the full text of our forward-looking statements there.
As a brief reminder, we anticipate making projections during this call and actual results could differ materially due to a number of factors, including those outlined in our latest filings with the SEC.
Adrian Rawcliffe, our Chief Executive Officer; and Elliot Norry, our acting Chief Medical Officer, are with me for the prepared portion of this call. Bill Bertrand, our Chief Operating Officer; Helen
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |